Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

UNIQUE LAB SOLUTIONS LLC

NPI: 1427514025 · DEARBORN HEIGHTS, MI 48127 · Clinical Medical Laboratory · NPI assigned 02/19/2019

$228K
Total Medicaid Paid
5,818
Total Claims
4,636
Beneficiaries
3
Codes Billed
2020-11
First Month
2022-05
Last Month

Provider Details

Authorized OfficialJANKOWSKI, JENNA (MANAGING MEMBER)
NPI Enumeration Date02/19/2019

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 210 $9K
2021 4,926 $192K
2022 682 $27K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,916 2,322 $176K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,889 2,301 $50K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 13 13 $2K